IL246417B - Genetic markers related to suicide risk and methods of using them - Google Patents
Genetic markers related to suicide risk and methods of using themInfo
- Publication number
- IL246417B IL246417B IL246417A IL24641716A IL246417B IL 246417 B IL246417 B IL 246417B IL 246417 A IL246417 A IL 246417A IL 24641716 A IL24641716 A IL 24641716A IL 246417 B IL246417 B IL 246417B
- Authority
- IL
- Israel
- Prior art keywords
- methods
- genetic markers
- markers associated
- suicide risk
- suicide
- Prior art date
Links
- 206010010144 Completed suicide Diseases 0.000 title 1
- 230000002068 genetic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C99/00—Subject matter not provided for in other groups of this subclass
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Data Mining & Analysis (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361920332P | 2013-12-23 | 2013-12-23 | |
| PCT/CA2014/051257 WO2015095967A1 (en) | 2013-12-23 | 2014-12-23 | Genetic markers associated with suicide risk and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL246417A0 IL246417A0 (en) | 2016-08-31 |
| IL246417B true IL246417B (en) | 2020-08-31 |
Family
ID=53477254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL246417A IL246417B (en) | 2013-12-23 | 2016-06-23 | Genetic markers related to suicide risk and methods of using them |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10435748B2 (https=) |
| EP (1) | EP3087203B1 (https=) |
| JP (1) | JP6679486B2 (https=) |
| KR (1) | KR20160111925A (https=) |
| CN (1) | CN106062213A (https=) |
| AU (1) | AU2014373588B2 (https=) |
| CA (1) | CA2934815C (https=) |
| IL (1) | IL246417B (https=) |
| SG (1) | SG11201605150YA (https=) |
| WO (1) | WO2015095967A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2891830A1 (en) | 2015-05-15 | 2016-11-15 | Centre For Addiction And Mental Health | Genetic markers for suicide risk and related methods |
| JP2019520315A (ja) * | 2016-04-29 | 2019-07-18 | スパーナス ファーマシューティカルズ インコーポレイテッド | 衝動的攻撃性を監視、診断、及び治療する方法、システム、及びキット |
| CN108531569B (zh) * | 2017-03-03 | 2021-05-07 | 上海伯豪医学检验所有限公司 | 用于强迫症与精神分裂症、抑郁症甄别的基因标志物及其应用 |
| CN108148905A (zh) * | 2018-02-13 | 2018-06-12 | 广州市番禺区中心医院(广州市番禺区人民医院、广州市番禺区心血管疾病研究所) | 一段可作为抑郁症标记物的序列 |
| WO2020235721A1 (ko) * | 2019-05-23 | 2020-11-26 | 울산과학기술원 | 다중 오믹스 분석을 이용한 우울증 또는 자살 위험 예측용 마커 발굴 방법, 우울증 또는 자살 위험 예측용 마커, 및 다중 오믹스 분석을 이용한 우울증 또는 자살 위험 예측 방법 |
| WO2024215722A1 (en) * | 2023-04-10 | 2024-10-17 | Board Of Regents, The University Of Texas System | Methods and compositions for diagnosing and treating depression and suicide risk |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USH2191H1 (en) * | 2000-10-24 | 2007-06-05 | Snp Consortium | Identification and mapping of single nucleotide polymorphisms in the human genome |
| US7361468B2 (en) * | 2004-07-02 | 2008-04-22 | Affymetrix, Inc. | Methods for genotyping polymorphisms in humans |
| US20120094855A1 (en) * | 2008-09-18 | 2012-04-19 | Max Planck Society | Means and methods for diagnosing predisposition for treatment emergent suicidal ideation (tesi) |
| EP2166112B1 (en) | 2008-09-18 | 2013-06-05 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Means and methods for diagnosing predisposition for treatment emergent suicidal ideation |
| KR101249635B1 (ko) * | 2010-10-13 | 2013-04-01 | 서울대학교산학협력단 | 양극성 장애 진단용 ｅｇｒ2 유전자 ｓｎｐ, 그를 포함하는 마이크로어레이 및 키트 |
-
2014
- 2014-12-23 CN CN201480076117.6A patent/CN106062213A/zh active Pending
- 2014-12-23 WO PCT/CA2014/051257 patent/WO2015095967A1/en not_active Ceased
- 2014-12-23 SG SG11201605150YA patent/SG11201605150YA/en unknown
- 2014-12-23 CA CA2934815A patent/CA2934815C/en active Active
- 2014-12-23 JP JP2016542129A patent/JP6679486B2/ja active Active
- 2014-12-23 EP EP14873830.5A patent/EP3087203B1/en not_active Not-in-force
- 2014-12-23 KR KR1020167019492A patent/KR20160111925A/ko not_active Withdrawn
- 2014-12-23 US US15/107,437 patent/US10435748B2/en active Active
- 2014-12-23 AU AU2014373588A patent/AU2014373588B2/en not_active Ceased
-
2016
- 2016-06-23 IL IL246417A patent/IL246417B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP3087203A1 (en) | 2016-11-02 |
| US20170002412A1 (en) | 2017-01-05 |
| CA2934815A1 (en) | 2015-07-02 |
| EP3087203A4 (en) | 2017-09-20 |
| WO2015095967A1 (en) | 2015-07-02 |
| SG11201605150YA (en) | 2016-07-28 |
| CN106062213A (zh) | 2016-10-26 |
| CA2934815C (en) | 2022-01-04 |
| AU2014373588B2 (en) | 2021-04-01 |
| KR20160111925A (ko) | 2016-09-27 |
| AU2014373588A1 (en) | 2016-07-21 |
| JP2017503493A (ja) | 2017-02-02 |
| US10435748B2 (en) | 2019-10-08 |
| IL246417A0 (en) | 2016-08-31 |
| EP3087203B1 (en) | 2019-09-11 |
| JP6679486B2 (ja) | 2020-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL246223A0 (en) | fcrn antagonists and their use | |
| IL244665A0 (en) | Conjugates of chlorotoxin and methods of using them | |
| EP2943202A4 (en) | IRAQ INHIBITORS AND USES THEREOF | |
| IL246221B (en) | Endazoles and their uses | |
| IL244296A0 (en) | Cell-permeable conjugates and methods of using them | |
| IL245839B (en) | Inhibitors of rna polymerase i and use of preparations containing them for treatment | |
| IL253160A0 (en) | Cancer markers and methods of using them | |
| AP2015008835A0 (en) | Biocidal systems and methods of use | |
| AP2016009207A0 (en) | Genetic markers and uses therefor | |
| SG11201504771RA (en) | Host cells and methods of use | |
| IL244214A0 (en) | Thienopiperidine derivative and its use | |
| PT2967044T (pt) | Composição herbicida e seu método de uso | |
| IL246417A0 (en) | Genetic markers related to suicide risk and methods of using them | |
| IL243433B (en) | Titanium bibory layers and their production | |
| EP3027182A4 (en) | Novel copper-cysteamine and methods of use | |
| PL2994150T3 (pl) | Probiotyki i sposoby zastosowania | |
| IL245272B (en) | pif-transfected cells and methods of use | |
| GB201309178D0 (en) | Enzyme and uses thereof | |
| IL245159A0 (en) | Genetic markers of an antipsychotic drug for weight gain and methods of using them | |
| SG11201601263WA (en) | Recombinant microorganisms and methods of use thereof | |
| WO2014202624A9 (en) | Rasamsonia gene and use thereof | |
| GB201518882D0 (en) | Agrochemical composition and method of use thereof | |
| ZA201600203B (en) | Axmi422 toxin gene and methods for its use | |
| ZA201600204B (en) | Axmi440 toxin gene and methods for its use | |
| AU2014903514A0 (en) | Markers of Disease Susceptibility and Onset and Uses Therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |